Witnessing the stock’s movement on the chart, on Wednesday, Transmedics Group Inc (NASDAQ: TMDX) set off with pace as it heaved 3.55% to $134.32, before settling in for the price of $129.71 at the close. Taking a more long-term approach, TMDX posted a 52-week range of $55.00-$145.50.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 140.37%. This publicly-traded company’s shares outstanding now amounts to $34.04 million, simultaneously with a float of $32.94 million. The organization now has a market capitalization sitting at $4.58 billion. At the time of writing, stock’s 50-day Moving Average stood at $116.61, while the 200-day Moving Average is $102.15.
Transmedics Group Inc (TMDX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Transmedics Group Inc’s current insider ownership accounts for 3.36%, in contrast to 109.69% institutional ownership. Preceding that transaction, on Aug 06 ’25, Company’s President & CEO bought 8,400 for 118.68, making the whole transaction’s value amount to 996,912. This particular insider is now the holder of 477,759 in total.
Transmedics Group Inc (TMDX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.72 per share during the current fiscal year.
Transmedics Group Inc’s EPS increase for this current 12-month fiscal period is 140.37% and is forecasted to reach 2.74 in the upcoming year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
Let’s observe the current performance indicators for Transmedics Group Inc (TMDX). It’s Quick Ratio in the last reported quarter now stands at 9.17. Alongside those numbers, its PE Ratio stands at $69.46, and its Beta score is 2.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.62. Similarly, its price to free cash flow for trailing twelve months is now 263.92.
In the same vein, TMDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.93, a figure that is expected to reach 0.39 in the next quarter, and analysts are predicting that it will be 2.74 at the market close of one year from today.
Technical Analysis of Transmedics Group Inc (TMDX)
Going through the that latest performance of [Transmedics Group Inc, TMDX]. Its last 5-days volume of 1.14 million was inferior to the volume of 1.25 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 86.53% While, its Average True Range was 75.16.
Raw Stochastic average of Transmedics Group Inc (TMDX) in the period of the previous 100 days is set at 76.01%, which indicates a major fall in contrast to 89.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 5.79 that was higher than 5.63 volatility it exhibited in the past 100-days period.
